1. Signaling Pathways
  2. Others
  3. Amino Acid Derivatives

Amino Acid Derivatives

Amino Acid Derivatives are bioactive molecules formed through chemical modifications or metabolic transformations of amino acids. They are widely present in living organisms and play crucial roles in physiological, psychological, and athletic performance.
The functions of these derivatives primarily include enhancing energy supply, regulating neurotransmitters, promoting fat metabolism, and reducing muscle damage. For example, creatine can increase muscle strength, enhance ATP resynthesis, and improve short-duration high-intensity exercise performance; tyrosine, as a precursor of dopamine and norepinephrine, helps enhance cognitive function and improve mood, particularly in sleep deprivation conditions, exhibiting anti-fatigue effects; carnitine facilitates fatty acid oxidation in the heart and skeletal muscles, improving endurance performance; HMB (β-hydroxy-β-methylbutyrate) reduces muscle breakdown and promotes muscle mass gain; while taurine exhibits antioxidant and antihypertensive properties and reduces oxidative stress induced by exercise.
Metabolic abnormalities or improper supplementation of amino acid derivatives may be associated with various diseases. For instance, tyrosine metabolism disorders can disrupt neurotransmitter balance, potentially leading to depression or stress-related disorders; elevated ADMA (asymmetric dimethylarginine) levels can inhibit nitric oxide synthesis, increasing the risk of cardiovascular diseases; carnitine deficiency is linked to certain genetic muscle disorders, impairing fat metabolism and energy production. Additionally, HMB may help slow muscle loss under specific conditions, while taurine intake is associated with improved cardiovascular health. Although some of the effects of these derivatives remain debated, they hold significant potential applications in sports nutrition, neurological regulation, and metabolic health.

Amino Acid Derivatives Related Products (1590):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W011049
    (S)-6-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoic acid
    99.11%
    (S)-6-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoic acid is a lysine derivative.
    (S)-6-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoic acid
  • HY-W006063
    (R)-3-Amino-4-hydroxybutanoic acid
    (R)-3-Amino-4-hydroxybutanoic acid is a serine derivative.
    (R)-3-Amino-4-hydroxybutanoic acid
  • HY-W027230
    N-[4-(Morpholin-4-ylsulfonyl)benzoyl]glycine
    N-[4-(Morpholin-4-ylsulfonyl)benzoyl]glycine is a Glycine (HY-Y0966) derivative.
    N-[4-(Morpholin-4-ylsulfonyl)benzoyl]glycine
  • HY-42067
    (tert-Butoxycarbonyl)-D-aspartic acid
    99.89%
    (tert-Butoxycarbonyl)-D-aspartic acid is an aspartic acid derivative.
    (tert-Butoxycarbonyl)-D-aspartic acid
  • HY-P4288
    Beta-Asp-His
    Beta-Asp-His is a dipeptide containing aspartic acid and histidine, which can form amino acid derivatives by complexing with Zinc.
    Beta-Asp-His
  • HY-W011073
    Boc-Tyr(Bzl)-OH
    Boc-Tyr(Bzl)-OH is a tyrosine derivative.
    Boc-Tyr(Bzl)-OH
  • HY-126835
    A924
    A 924 is an amino acid derivative-based, orally active antitumor agent. A 924 is effective in inhibiting ascites tumors in rat models by intraperitoneal injection or oral administration. The LD50 of A 924 in mice is >1.5 g/kg and >4.5 g/kg by intraperitoneal injection or oral administration, respectively. A 924 does not cause teratogenicity or adverse reactions in normal or pregnant mice.
    A924
  • HY-W141933
    N-Succinylglycine
    N-Succinylglycine is a Glycine (HY-Y0966) derivative.
    N-Succinylglycine
  • HY-W015241
    Ac-D-Glu-OH
    Ac-D-Glu-OH is a glutamic acid derivative.
    Ac-D-Glu-OH
  • HY-W005226
    2-Amino-2-(4-hydroxyphenyl)acetic acid
    2-Amino-2-(4-hydroxyphenyl)acetic acid is a Glycine (HY-Y0966) derivative.
    2-Amino-2-(4-hydroxyphenyl)acetic acid
  • HY-W770952
    DL-Phenylmercapturic Acid-13C6
    DL-Phenylmercapturic Acid-13C6 (N-Acetyl-S-phenyl-L-cysteine-13C6) is the 13C-labeled DL-Phenylmercapturic Acid (HY-W141770). DL-Phenylmercapturic Acid is a cysteine derivative.
    DL-Phenylmercapturic Acid-<sup>13</sup>C<sub>6</sub>
  • HY-35028
    Boc-Glu-Ofm
    Boc-Glu-Ofm is a peptide. Boc-Glu-Ofm has been used for the synthesis of ester insulin and cyclic peptide mixtures.
    Boc-Glu-Ofm
  • HY-W142019
    Benzoyl-DL-leucine
    Benzoyl-DL-leucine is a leucine derivative.
    Benzoyl-DL-leucine
  • HY-W039180
    Methyl (tert-butoxycarbonyl)-D-leucinate
    Methyl (tert-butoxycarbonyl)-D-leucinate is a leucine derivative.
    Methyl (tert-butoxycarbonyl)-D-leucinate
  • HY-W701588
    Boc-D-Chg-OH-d11
    Boc-D-Chg-OH-d11 is the deuterium labeled Boc-D-Chg-OH (HY-W011832). Boc-D-Chg-OH is a Glycine (HY-Y0966) derivative.
    Boc-D-Chg-OH-d<sub>11</sub>
  • HY-W011279
    Z-D-Asp(OtBu)-OH
    Z-D-Asp(OtBu)-OH is an aspartic acid derivative.
    Z-D-Asp(OtBu)-OH
  • HY-101242
    (±)-α-Methyl-(4-sulfonophenyl)glycine
    (±)-α-Methyl-(4-sulfonophenyl)glycine is a Glycine (HY-Y0966) derivative.
    (±)-α-Methyl-(4-sulfonophenyl)glycine
  • HY-P4296
    H-Gly-Sar-Sar-OH
    H-Gly-Sar-Sar-OH is an orally active tripeptide. H-Gly-Sar-Sar-OH is transported through PepT1 within Caco-2 cells. H-Gly Sar Sar OH has potential applications in material transportation.
    H-Gly-Sar-Sar-OH
  • HY-W009339
    Z-Gln-OH
    Z-Gln-OH is a glutamine derivative.
    Z-Gln-OH
  • HY-100177
    L-Threonine derivative-1
    L-Threonine derivative-1 is a acetylsalicylic-L-threonine ester extracted from patent US 20060287244 A1.
    L-Threonine derivative-1